a couple of thousand pre-teen agers and it appears to us from the f.d.a. and merck information regarding gardasil that the vaccine they tried on the preteens is not the same as what was then put on the market as gardasil for you know gardasil now it's on the market in the u.s. is gardasil nine the other thing that jumps out there wasn't tested properly in the target population now does. being expanded to adults we have very serious concerns that people who happen to have h.p.v. viral infections at the time of vaccination or if they've already cleared an infection the clinical trial data shows they may be at increased risk of getting a cervical viral infection that's a big problem in other words the people who got the vaccine if they had an active infection they were at higher risk of getting lesions that might lead to cancer and there's no screening that's recommended for people who get this vaccine so that's a huge problem i mean we really the bottom line is this wasn't properly...